AR127182A1 - DERIVADOS DE AMINA BICÍCLICOS COMO MODULADORES DE RECEPTOR GABAA a5 - Google Patents

DERIVADOS DE AMINA BICÍCLICOS COMO MODULADORES DE RECEPTOR GABAA a5

Info

Publication number
AR127182A1
AR127182A1 ARP220102623A ARP220102623A AR127182A1 AR 127182 A1 AR127182 A1 AR 127182A1 AR P220102623 A ARP220102623 A AR P220102623A AR P220102623 A ARP220102623 A AR P220102623A AR 127182 A1 AR127182 A1 AR 127182A1
Authority
AR
Argentina
Prior art keywords
receptor
receptor modulators
gabaa receptor
amine derivatives
gabaa
Prior art date
Application number
ARP220102623A
Other languages
English (en)
Spanish (es)
Inventor
Lis Olivr Dr
Bata Imre Dr
Erdlyi Pter Dr
Kapus Gbor Lszl Dr
Attila Potor
Gyrgy Szab
Trs Gyrgy Istvn Dr
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of AR127182A1 publication Critical patent/AR127182A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
ARP220102623A 2021-09-29 2022-09-29 DERIVADOS DE AMINA BICÍCLICOS COMO MODULADORES DE RECEPTOR GABAA a5 AR127182A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUP2100338A HU231691B1 (hu) 2021-09-29 2021-09-29 GABAA ALFA5 receptor modulátor hatású biciklusos aminszármazékok

Publications (1)

Publication Number Publication Date
AR127182A1 true AR127182A1 (es) 2023-12-27

Family

ID=89993434

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220102623A AR127182A1 (es) 2021-09-29 2022-09-29 DERIVADOS DE AMINA BICÍCLICOS COMO MODULADORES DE RECEPTOR GABAA a5

Country Status (20)

Country Link
US (1) US20250051323A1 (cg-RX-API-DMAC7.html)
EP (1) EP4408842A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024536039A (cg-RX-API-DMAC7.html)
KR (1) KR20240089056A (cg-RX-API-DMAC7.html)
CN (1) CN118284606A (cg-RX-API-DMAC7.html)
AR (1) AR127182A1 (cg-RX-API-DMAC7.html)
CA (1) CA3231776A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024000893A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024005424A2 (cg-RX-API-DMAC7.html)
CU (1) CU20240013A7 (cg-RX-API-DMAC7.html)
EC (1) ECSP24032316A (cg-RX-API-DMAC7.html)
GE (2) GEAP202416510A (cg-RX-API-DMAC7.html)
HU (1) HU231691B1 (cg-RX-API-DMAC7.html)
IL (1) IL311640A (cg-RX-API-DMAC7.html)
JO (1) JOP20240057A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024003812A (cg-RX-API-DMAC7.html)
PE (1) PE20240816A1 (cg-RX-API-DMAC7.html)
TW (1) TW202330518A (cg-RX-API-DMAC7.html)
WO (1) WO2023053015A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202403230B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024251133A1 (zh) * 2023-06-05 2024-12-12 武汉人福创新药物研发中心有限公司 作为α5-GABAA受体调节剂的杂环化合物及其用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230518B1 (hu) 2005-12-20 2016-10-28 Richter Gedeon Nyrt. Bradykinin B1 receptor szelektív antagonista hatással rendelkező új fenatridin származékok, eljárás előállításukra, és az ezeket tartalmazó gyógyszerkészítmények
HUP0600809A3 (en) 2006-10-27 2008-09-29 Richter Gedeon Nyrt New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
HUP0600810A3 (en) 2006-10-27 2008-09-29 Richter Gedeon Nyrt New sulfonamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
HUP0600808A3 (en) 2006-10-27 2008-09-29 Richter Gedeon Nyrt New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
US8742097B2 (en) * 2010-11-09 2014-06-03 Hoffmann-La Roche Inc. Triazole compounds I
WO2014001278A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
EP2885290B1 (en) 2012-06-26 2017-10-18 Saniona A/S A phenyl triazole derivative and its use for modulating the gabaa receptor complex
WO2014001279A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
HUP1300139A2 (en) 2013-03-06 2014-09-29 Richter Gedeon Nyrt Phenoxypiperidine h3 antagonists
EP4032889B1 (en) 2013-12-20 2026-05-06 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
EP4129297A1 (en) 2016-03-18 2023-02-08 UWM Research Foundation, Inc. Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with alpha5-containing gabaa receptor agonists
MA48594B1 (fr) 2016-12-08 2022-05-31 Hoffmann La Roche Nouveaux dérivés d'éther d'isoxazolyle en tant que pam alpha5 gaba a
HU231057B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok
HU231058B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt. Gyógyászatilag hatékony aliciklusos-szubsztituált pirazolo[1,5-a]pirimidin származékok
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素V1a受體拮抗劑之三環化合物
HU231206B1 (hu) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek
AU2019286312B2 (en) 2018-06-13 2023-08-17 F. Hoffmann-La Roche Ag New isoxazolyl ether derivatives as GABA A alpha5 PAM
HU231333B1 (hu) 2018-07-13 2023-01-28 Richter Gedeon Nyrt Spirokromán származékok
HU231478B1 (hu) 2018-07-13 2024-02-28 Richter Gedeon Nyrt. Szubsztituált (aza)indol származékok
HU231414B1 (hu) 2018-07-13 2023-08-28 Richter Gedeon Nyrt. Tiadiazin származékok
BR102019014802A2 (pt) 2018-07-20 2020-02-04 Boehringer Ingelheim Int difluorometil-fenil triazóis
HU231223B1 (hu) * 2018-09-28 2022-01-28 Richter Gedeon Nyrt. GABAA A5 receptor modulátor hatású biciklusos vegyületek
TWI901650B (zh) * 2020-03-26 2025-10-21 匈牙利商羅特格登公司 啶及吡啶并〔3,4-c〕嗒衍生物

Also Published As

Publication number Publication date
HUP2100338A1 (hu) 2023-04-28
PE20240816A1 (es) 2024-04-18
AU2022357572B2 (en) 2026-08-06
GEP20257812B (en) 2025-10-27
CO2024005424A2 (es) 2024-05-10
MX2024003812A (es) 2024-04-25
GEAP202416510A (en) 2024-08-12
US20250051323A1 (en) 2025-02-13
CN118284606A (zh) 2024-07-02
TW202330518A (zh) 2023-08-01
JP2024536039A (ja) 2024-10-04
WO2023053015A1 (en) 2023-04-06
ECSP24032316A (es) 2024-05-31
EP4408842A1 (en) 2024-08-07
ZA202403230B (en) 2024-12-18
CA3231776A1 (en) 2023-04-06
HU231691B1 (hu) 2025-10-28
KR20240089056A (ko) 2024-06-20
AU2022357572A1 (en) 2024-05-02
CL2024000893A1 (es) 2024-09-06
CU20240013A7 (es) 2024-11-15
IL311640A (en) 2024-05-01
JOP20240057A1 (ar) 2024-03-20

Similar Documents

Publication Publication Date Title
CL2021003012A1 (es) Inhibidores del inflamasoma nlrp3
CO2021000537A2 (es) Inhibidores de inflamasoma nlrp3
CO2022015054A2 (es) [1,3]diazino[5,4-d]pirimidinas como inhibidores de her2
CL2021000907A1 (es) Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1 (divisional de solicitud n° 01501-2020)
MX2022011354A (es) Compuestos de pirimidina fusionados como moduladores de kcc2.
CO2022014877A2 (es) Derivados de naftiridina y pirido[3,4-c]piridazina como moduladores del receptor gabaa α5
BR112019018648A2 (pt) Inibidores de jak contendo uma amida heterocíclica com 4 membros
CR10614A (es) Derivados heterociclicos fusionados y metodos de uso
CL2008002768A1 (es) Compuestos derivados de carboxiciclopropil-(bis-fenil-oxamidas); composicion farmaceutica que los contiene; procedimiento para la elaboracion de las composiciones y el uso de los compuestos en el tratamiento de diabetes y trastornos del sncentre otras enfermedades.
UY29827A1 (es) 2-amina-pirimidina-4-(2-metil-1-(tetrahidro-2h-piran-4-il)-1-imidazol-5-y1) sustituidas y sus derivados, composiciones farmacéuticas que las contienen, procesos para su preparación y aplicaciones
ECSP19072975A (es) Derivados pirazol[1,5-a]pirimidina sustituidos con alicíclicos farmacológicamente activos
CL2020001140A1 (es) Compuestos espirocíclicos como moduladores del receptor farnesoide x.
AR123685A1 (es) Antagonistas del mrgx2
MX2020011405A (es) Derivados de bencimidazol como moduladores del receptor gamma huerfano (rory) relacionado con retinoide y usos farmaceuticos de los mismos.
UY38228A (es) Compuestos de triazolopirimidina y su uso en el tratamiento del cáncer
CL2020001564A1 (es) Triazolobenzazepinas como antagonistas del receptor v1a de la vasopresina.
MX2024008372A (es) Compuestos organicos deuterados y usos de los mismos
EA202190857A1 (ru) Бициклические производные как модуляторы 5 рецепторов gabaa
CO2022008313A2 (es) Compuestos químicos
CO2024003953A2 (es) Derivados de benzodiazepina como moduladores alostéricos positivos del receptor de gaba a gamma1
MX2020007443A (es) Derivados de 2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidin-5-ona y compuestos relacionados como moduladores del receptor c5a para el tratamiento de vasculitis y enfermedades inflamatorias.
CO2024005424A2 (es) Derivados de amina bicíclicos como moduladores de receptor gabaa α5
CL2025000120A1 (es) Compuestos de piridinona sustituida como inhibidores de cbl-b.
UY37745A (es) Compuestos bicíclicos 5,6 fusionados y composiciones para el tratamiento de las enfermedades parasitarias
ES3063880T3 (en) Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-ht4 receptor agonists